National Bank of Canada’s Pfizer PFE Stock Holding History

National Bank of Canada’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$144M	Buy	5,136,267 +234,500	+5%	+$6.24M	0.13%	139
2025 Q4	$122M	Buy	4,901,767 +97,450	+2%	+$2.46M	0.11%	158
2025 Q3	$122M	Sell	4,804,317 -3,784,452	-44%	-$93.4M	0.12%	148
2025 Q2	$208M	Sell	8,588,769 -1,175,674	-12%	-$27.4M	0.2%	100
2025 Q1	$247M	Sell	9,764,443 -1,796,036	-16%	-$47M	0.26%	82
2024 Q4	$307M	Buy	11,560,479 +2,925,269	+34%	+$79.3M	0.32%	63
2024 Q3	$250M	Sell	8,635,210 -1,893,867	-18%	-$55.2M	0.29%	63
2024 Q2	$297M	Sell	10,529,077 -2,407,601	-19%	-$66.3M	0.41%	44
2024 Q1	$362M	Buy	12,936,678 +5,286,849	+69%	+$147M	0.55%	35
2023 Q4	$227M	Sell	7,649,829 -5,689,347	-43%	-$172M	0.36%	57
2023 Q3	$453M	Buy	13,339,176 +5,132,386	+63%	+$181M	0.69%	26
2023 Q2	$301M	Buy	8,206,790 +6,676,325	+436%	+$260M	0.55%	34
2023 Q1	$62.4M	Sell	1,530,465 -2,105,480	-58%	-$90.9M	0.15%	123
2022 Q4	$186M	Buy	3,635,945 +1,847,433	+103%	+$88.6M	0.47%	46
2022 Q3	$78.3M	Buy	1,788,512 +230,867	+15%	+$11.2M	0.42%	50
2022 Q2	$81.7M	Buy	1,557,645 +242,059	+18%	+$12.3M	0.37%	63
2022 Q1	$67.8M	Sell	1,315,586 -2,160,269	-62%	-$112M	0.2%	109
2021 Q4	$205M	Buy	+3,475,855	New	+$172M	0.7%	27

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

National Bank of Canada's PFE Position: Q1 2026 in Review

National Bank of Canada increased its Pfizer (PFE) stake by 4.8% in Q1 2026, buying an estimated $6.24M and bringing the position to 5,136,267 shares worth $144M. The position accounts for 0.13% of the portfolio, ranked #139.

National Bank of Canada first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $453M in Q3 2023. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

National Bank of Canada held 5,136,267 shares of Pfizer worth $144M as of Q1 2026.
National Bank of Canada bought 234,500 Pfizer shares in Q1 2026, an estimated $6.24M.
Pfizer made up 0.13% of National Bank of Canada's portfolio in Q1 2026, its #139 holding.
National Bank of Canada first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
National Bank of Canada's Pfizer position peaked at $453M in Q3 2023.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.